- Home
- NVCR vs ASTH Comparison
NVCR vs ASTH Comparison
Compare NVCR & ASTH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVCR
- ASTH
- Stock Information
- Founded
- NVCR 2000
- ASTH 1994
- Country
- NVCR Switzerland
- ASTH United States
- Employees
- NVCR N/A
- ASTH N/A
- Industry
- NVCR Medical/Dental Instruments
- ASTH Professional Services
- Sector
- NVCR Health Care
- ASTH Consumer Discretionary
- Exchange
- NVCR Nasdaq
- ASTH Nasdaq
- Market Cap
- NVCR 1.9B
- ASTH 1.7B
- IPO Year
- NVCR 2015
- ASTH N/A
- Fundamental
- Price
- NVCR $15.58
- ASTH $31.38
- Analyst Decision
- NVCR Buy
- ASTH Strong Buy
- Analyst Count
- NVCR 6
- ASTH 8
- Target Price
- NVCR $34.17
- ASTH $53.29
- AVG Volume (30 Days)
- NVCR 736.7K
- ASTH 322.1K
- Earning Date
- NVCR 04-24-2025
- ASTH 05-08-2025
- Dividend Yield
- NVCR N/A
- ASTH N/A
- EPS Growth
- NVCR N/A
- ASTH N/A
- EPS
- NVCR N/A
- ASTH 0.90
- Revenue
- NVCR $605,220,000.00
- ASTH $2,034,540,000.00
- Revenue This Year
- NVCR $3.14
- ASTH $36.05
- Revenue Next Year
- NVCR $10.63
- ASTH $21.97
- P/E Ratio
- NVCR N/A
- ASTH $34.87
- Revenue Growth
- NVCR 18.82
- ASTH 46.72
- 52 Week Low
- NVCR $11.70
- ASTH $23.12
- 52 Week High
- NVCR $34.13
- ASTH $63.20
- Technical
- Relative Strength Index (RSI)
- NVCR 34.24
- ASTH 48.59
- Support Level
- NVCR $15.49
- ASTH $30.20
- Resistance Level
- NVCR $17.06
- ASTH $34.15
- Average True Range (ATR)
- NVCR 1.06
- ASTH 2.04
- MACD
- NVCR -0.01
- ASTH 0.28
- Stochastic Oscillator
- NVCR 20.42
- ASTH 57.45
About NVCR NovoCure Limited
NovoCure Ltd serves in the healthcare sector of the United States. Its business involves the development, manufacture and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis and other products and technologies for the treatment of Glioblastoma, Non-smell cell lung cancer and Pancreatic cancer. Geographically, the company derives majority of its revenue from the United States and rest from Germany, Japan and other markets.
About ASTH Astrana Health Inc. Common Stock
Astrana Health Inc is a patient-centered, physician-centric integrated population health management company. The company is working to provide coordinated, outcomes-based medical care cost-effectively. It is focused on physicians providing high-quality medical care, population health management, and care coordination for patients, particularly senior patients and patients with multiple chronic conditions. Its operating segment is the healthcare delivery segment.